Search

Search Constraints

You searched for: Author/Creator Navarra, Sandra V

Search Results

1. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Issue 9 (12th October 2015)

2. Does hydroxychloroquine improve patient reported outcomes in patients with lupus?. (October 2021)

3. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Issue 11 (1st May 2012)

4. Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study. (October 2019)

5. Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension. (13th July 2019)

6. Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study. (December 2022)

7. Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study. (October 2019)

8. Overview of lupus nephritis management guidelines and perspective from Asia. Issue 1 (January 2014)

9. Strong viral associations with SLE among Filipinos. Issue 1 (28th July 2017)

10. Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Issue 5 (10th January 2012)